Small cell cancer is alive without chemotherapy

Small cell lung cancer (SCLC) is a highly malignant form of lung cancer. If no treatment is given, the survival time is generally no more than one year. If advanced SCLC, the survival time is about three months to six months. However, SCLC is a malignant tumor that is sensitive to chemotherapy. If the patient cannot withstand chemotherapy or is unwilling to undergo chemotherapy for other reasons, targeted drug therapy can be selected. Commonly used targeted drugs are mainly tyrosine kinase inhibitors, such as gefitinib and other drugs, which can effectively control tumor growth and effectively prolong the survival of patients.